The S&P 500 closed at a record 7,757.46, up 3.57% on the week, after July payrolls contracted 23,000 against an +83,000 consensus and priced a September rate hike out of the front end — over the objections of five Fed officials who spent four sessions arguing for one. Crude round-tripped 8.8% lower on the Hormuz reopening trade, leaving Energy down 3.66% with the strait still shut. Palantir surged 39.78%; AMD beat on every line and fell 7% on its capex.
Tag Archives | AstraZeneca
MIB Weekly: The Market Outvoted Five Fed Hawks and Bought a Record on a 23K Job Loss — AI Now Pays for Capital Discipline, Not Growth, and a Beat Buys Nothing; Wednesday’s CPI Can Undo All of It
Read full story · Comments are closed
MIB Daily: Oil Did the Fed’s Job Today — WTI’s 5.52% Crash Funds a Record Dow and a $3T Amazon, But Chips and Transports Aren’t Buying the Truce
Trump called off strikes on Iran and crude cratered — WTI -5.52% to $80 — but Tehran denies talking to Washington and Hormuz stays shut. The Dow closed at a record 53,178.41, and this time breadth came along: 8 of 11 sectors green, Russell +1.72%. ISM manufacturing hit a post-2022 high and GDPNow leapt to 6.2%; bonds rallied anyway. Williams says the Fed hikes if inflation stalls. AstraZeneca-Bristol Myers weighed a $400bn merger; AZN fell 9%. Amazon topped $3 trillion.
Read full story · Comments are closed
MIB: $100 Oil, Five Straight Down Weeks, and a Consumer Sentiment Reading From the Abyss
WTI crude above $100 for first time since 2022; Trump’s Iran deadline extension did nothing to calm markets. Dow enters correction; S&P posts 5th straight losing week — worst streak in 4 years. Macquarie warns 40% chance of $200 oil, $7/gallon gasoline if war lasts to June. Gold surges to $4,521/oz as VIX spikes 13% to 31. AZN +2.74% on Phase 3 COPD breakthrough. UMich crashes to 53.3 — bottom 1st percentile of all-time survey history.
Read full story · Comments are closed